Brain Cancer

Brain Cancer News & Features

Patient receiving radiation therapy treatments for head and neck cancer

Strategies for Managing Postradiotherapy Cerebral Radiation Necrosis in Nontarget Brain Tissue

Bryant Furlow

December 11, 2019

This review seeks to shed light on a relatively common but poorly understood adverse effect of radiotherapy for primary and metastatic brain or head and neck tumors.

If crowdfunding doesn’t work, here’s how oncologists can help patients with financial toxicity.

The Disappointing Reality of Crowdfunding Cancer Care

Sarah Elizabeth Richards

October 22, 2019

If crowdfunding doesn’t work, here’s how oncologists can help patients with financial toxicity.

Ten different drugs continued to kill cancer cells even when their target proteins were removed.

Some Targeted Therapies May Miss the Mark

Caroline Seydel

October 17, 2019

Ten different drugs continued to kill cancer cells even when their target proteins were removed.

Administering bevacizumab before etoposide and cisplatin may be highly effective in patients with br

Ribociclib Shown to Penetrate the Blood-Brain Barrier in Glioblastoma

Devona Williams, PharmD, BCOP

September 25, 2019

A phase 0 study of ribociclib in patients with recurrent glioblastoma seeks to inform the feasibility of the use of CDK 4/6 inhibitors for deadly brain tumors.

Critics of the study say they are not surprised by the study’s conclusions, as oncologists make treatment decisions based on best treatment course, not money.

Enhanced Reimbursement Incentives for Generic Cancer Drugs Found Not to Affect Prescribing Patterns

Randi Hernandez

May 8, 2019

Critics of the study say they are not surprised by the study’s conclusions, as oncologists make treatment decisions based on best treatment course, not money.

Brain Cancer Clinical Trials

Higher Comorbidities Not Likely to Blame for Underrepresentation of African Americans in Clinical Trials, Studies of Acute Myeloid Leukemia

Researchers sought to determine if presence of comorbidities influences the underrepresentation of African American patients with acute myeloid leukemia in clinical trials.

Differences in Postrelapse Mortality May be Driving Racial/Ethnic Disparities Observed in Children With Hodgkin Lymphoma

No difference in event-free survival (EFS) was observed in children and adolescents with newly diagnosed Hodgkin lymphoma (HL) according to race/ethnicity; however, postrelapse mortality was found to be higher in nonwhite groups. The findings from this pooled, secondary analysis of data from phase 3 clinical trials of dose-dense, response-adapted therapy were published in the Journal…

Brain Cancer

Strategies for Managing Postradiotherapy Cerebral Radiation Necrosis in Nontarget Brain Tissue

The Disappointing Reality of Crowdfunding Cancer Care

Some Targeted Therapies May Miss the Mark

Ribociclib Shown to Penetrate the Blood-Brain Barrier in Glioblastoma

Enhanced Reimbursement Incentives for Generic Cancer Drugs Found Not to Affect Prescribing Patterns

Brain Cancer Clinical Trials

Higher Comorbidities Not Likely to Blame for Underrepresentation of African Americans in Clinical Trials, Studies of Acute Myeloid Leukemia

Differences in Postrelapse Mortality May be Driving Racial/Ethnic Disparities Observed in Children With Hodgkin Lymphoma

Use of PRO-CTCAE May Help Identify Underreported Adverse Effects in Phase 1 Clinical Trials

Complementary Medicine Use Is Common Among Participants in Phase 3 Clinical Trials

Clinical Trial Participation May Not Improve Outcomes in Socioeconomically Deprived Areas

Want to read more?